Related Experiment Video
Updated: Jan 1, 2026

A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
Published on: September 2, 2021
Strategies for the CRISPR-Based Therapeutics.
Bin Li1, Yuyu Niu2, Weizhi Ji2
1Department of Infectious Disease, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518020, China.
CRISPR genome editing technology, a microbial defense system, is now a powerful tool for genetic engineering. Researchers are improving its delivery and regulation for therapeutic applications in clinical trials.
Area of Science:
- Biotechnology
- Molecular Biology
- Genetics
Background:
- CRISPR-Cas is an RNA-guided nuclease system derived from microbial adaptive immunity.
- It has been repurposed as a versatile genome editing tool for eukaryotic systems.
- Significant efforts are focused on enhancing its efficiency and delivery methods.
Purpose of the Study:
- To review strategies for regulating and delivering CRISPR-Cas components.
- To outline current therapeutic applications and clinical translation of CRISPR-Cas technology.
Main Methods:
- Review of existing literature on CRISPR-Cas system improvements.
- Analysis of ex vivo and in vivo delivery strategies.
- Examination of preclinical and clinical trial data.
Main Results:
- Various methods have been developed to optimize CRISPR-Cas genome editing.
- Effective delivery systems are crucial for therapeutic applications.
- CRISPR-Cas is progressing towards clinical use in treating diseases.
Conclusions:
- CRISPR-Cas technology holds immense promise for genetic engineering and therapeutic interventions.
- Continued research into regulation and delivery will accelerate its clinical translation.
- The system's adaptability supports diverse applications in medicine.
More Related Videos
Related Concept Videos
CRISPR
CRISPR/Cas9 Genome Editing
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Homologous Recombination
The Antiviral System of Bacteria and Archaea: CRISPR
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

